Diaceutics PLC (DXRX.L) Stock Price
£137.5 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
7 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Diaceutics PLC, AI stock picks, stock alerts and much more.
DXRX.L AI Stock Analysis
AI stock analysis for DXRX.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Diaceutics PLC (DXRX.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Diaceutics PLC (DXRX.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Diaceutics PLC (DXRX.L), currently trading at £137.5, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About DXRX.L
-
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.
-
Symbol
DXRX.L
-
Market
LSE
-
Industry
Medical - Diagnostics & Research
-
Market Cap
116.2M
Similar Stocks
 |
Lonza Group AG 0QNO.L |
CHF569.6 0% |
6 |
 |
ANGLE AGL.L |
£6.5 4% |
4 |
 |
genedrive GDR.L |
£0.8 2.5% |
3 |
 |
Verici Dx VRCI.L |
£0.525 4.6% |
4 |
 |
PerkinElmer 0KHE.L |
$93.8 3.4% |
5 |
News
DXRX.L Alternative Data
Web Traffic
Diaceutics PLC receives an estimated 7360 monthly visitors to diaceutics.com.
-
Web Traffic
7360
-
Change from Previous Month
11.2%
-
3 Month Change
321.5%
-
YoY Change
321.5%
Twitter Followers
Diaceutics PLC has 2,370 Twitter Followers on its main Twitter (also known as X) account, which is up by 0% over the last month.
-
Twitter Followers
2370
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.1%
Facebook Engagement
Diaceutics PLC has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Youtube Subscribers
Diaceutics PLC has 138 subscribers on its main Youtube channel, up by 0.7% over the last month.
-
Youtube Subscribers
138
-
Daily Change
0.7%
-
1 Month Change
0.7%
-
3 Month Change
4.5%
Job Postings
Diaceutics PLC has an estimated 2 open job postings, which is down -83.3% over the last month.
-
Job Postings
2
-
Daily Change
0%
-
1 Month Change
83.3%
-
3 Month Change
83.3%
Reddit Mentions
Diaceutics PLC has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
17,862 are following Diaceutics PLC on LinkedIn, up by 0.5% over the last month.
-
LinkedIn Followers
17862
-
Daily Change
0.5%
-
1 Month Change
0.5%
-
3 Month Change
2.2%
LinkedIn Employees
According to LinkedIn, Diaceutics PLC has 216 employees, down by -0.5% over the last month.
-
LinkedIn Employees
216
-
Daily Change
0.5%
-
1 Month Change
0.5%
-
3 Month Change
4.3%
Business Outlook
According to employee reviews, the business outlook among employees at Diaceutics PLC is 70 out of 100 (bullish).
-
Business Outlook
70
-
Change from Previous Month
9.1%
-
3 Month Change
5.4%
-
YoY Change
5.4%
News Mentions
Diaceutics PLC was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
DXRX.L Financials
DXRX.L Key Metrics
-
Total Revenue
£12.3M
-
Net Income
-£2.6M
-
Earnings per Share
-£0.0306
-
Free cash flow
£1.4M
-
EBITDA
-£961K
-
EBITDA Ratio
-0.0780033
-
Total Assets
£45.4M
DXRX.L 2-year Revenue & Income
DXRX.L 2-year Free Cash Flow
DXRX.L Technicals
DXRX.L SMA
DXRX.L RSI
FAQ
What's the current price of Diaceutics PLC (DXRX.L) Stock?
The price of an Diaceutics PLC (DXRX.L) share is £137.5.
What's the market cap of Diaceutics PLC?
The current market cap of Diaceutics PLC is 116.2M.
Should I buy or sell DXRX.L?
Multiple alternative data signals suggest that Diaceutics PLC stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Diaceutics PLC a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Diaceutics PLC stock. The bullish indicators suggest that Diaceutics PLC's growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Diaceutics PLC (DXRX.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Diaceutics PLC stock, given the bullish outlook.
What are some stocks similar to Diaceutics PLC (DXRX.L) that investors often compare it to?
Diaceutics PLC (DXRX.L) is often compared to similar stocks such as Lonza Group AG, ANGLE, genedrive, Verici Dx and PerkinElmer.
What is the forecast for Diaceutics PLC's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Diaceutics PLC's stock price to be around £146.9 in 2026. Starting from the current price of £137.5, this represents a 6.9% change in price, indicating a bullish outlook for the stock.
How to buy Diaceutics PLC (DXRX.L) Stock?
Diaceutics PLC stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Diaceutics PLC shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.